Price
Target price
?
?
-1.030%
-0.1
-1.030%
€17.20
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Hutchison China MediTech Ltd ADR Stock
A loss of -1.030% shows a downward development for Hutchison China MediTech Ltd ADR.
We see a rather positive sentiment for Hutchison China MediTech Ltd ADR with 6 Buy predictions and 1 Sell predictions.
With a target price of 17 € there is a hugely positive potential of 77.08% for Hutchison China MediTech Ltd ADR compared to the current price of 9.6 €.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | -1.030% | 3.191% | 10.227% | -34.014% | -11.009% | -8.491% | -71.471% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -8.333% | 0.917% | -40.860% | -58.095% |
| China Resources Pharmaceutical Group Ltd | 0.000% | 5.263% | 6.996% | -9.565% | 9.244% | -22.388% | 7.884% |
| Repligen Corp. | -7.570% | 0.871% | 10.634% | 27.475% | -9.514% | -9.866% | -25.944% |
Comments
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $20.00 to $17.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $21.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
